FRESENIUS KABI ONCOLOGY LTD Inactive Instrument
Company Fresenius Kabi Oncology Ltd
Equities
INE575G01010
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| 2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
| 2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18-06-30 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
| Director/Board Member | - | 07-07-20 | |
| Director/Board Member | 63 | 08-08-10 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 08-08-10 | |
| Director/Board Member | - | 07-07-20 | |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
| Director/Board Member | - | 19-05-09 | |
| Chief Executive Officer | - | 18-06-30 | |
Maurizio Villa
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 480,427,326 | 0 | 0 | - |
Company contact information
Fresenius Kabi Oncology Ltd.
Echelon Institutional Area Plot No-11, Sector-32
122001, Gurgaon
+91 12 4488 5000
http://www.fresenius-kabi-oncology.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
- Stock Market
- Equities
- Stock
- Company Fresenius Kabi Oncology Ltd
